Publicacions destacades

α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment

Esteller-Gauxax, Diana; Perez Millan, Agnes; Sarto, Jordi; Puey, Roger; Guillen Soley, Nuria;

(...)

Auge Fradera, Josep Maria; Antonell, Anna; Sanchez-Valle, Raquel; Llado, Albert; Balasa, Mircea.

Referència:
Neurology 2025.
Blood-based biomarkers for Alzheimer's disease: Positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology

Suarez-Calvet, M; Abdelnour, C; Alcolea, D; Mendioroz-Iriarte, M; Balasa, M;

Morenas-Rodriguez, E; Puig-Pijoan, A; Sanchez-Juan, P; Villarejo-Galende, A; Sanchez-Valle, R.

Referència:
Neurologia 2025.
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

Bateman, RJ; Li, Y; McDade, EM; Llibre-Guerra, JJ; Clifford, DB;

(...)

Levin, J; Lopera, F; Roh, J; Rosa-Neto, P; Schofield, PR.

Referència:
Lancet Neurology 2025.
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study

Tort-Merino, A; Pérez-Millan, A; Falgàs, N; Borrego-ecija, S; Esteller, D;

(...)

Illán-Gala, I; Balasa, M; Lladó, A; Rami, L; Sánchez-Valle, R.

Referència:
Alzheimers & Dementia 2025.
Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia

Borrego-Ecija, S; Juncà-Parella, J; Vandebergh, M; Millan, AP; Balasa, M;

(...)

Moreno, F; Borroni, B; Rademakers, R; Rohrer, JD; Sánchez-Valle, R.

Referència:
Neurology 2024.
Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome

Carmona-Iragui, Maria; O 'Connor, Antoinette; Llibre-Guerra, Jorge; Lao, Patrick; Ashton, Nicholas J;

Fortea, Juan; Sanchez-Valle, Raquel.

Referència:
Ebiomedicine 2024.
Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's disease

Falgàs, N; Peña-González, M; Val-Guardiola, A; Pérez-Millan, A; Guillén, N;

(...)

Morales-Ruiz, M; Bargalló, N; Muñoz-Moreno, E; Grinberg, LT; Sánchez-Valle, R.

Referència:
Alzheimers & Dementia 2024.
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity

Borrego-Ecija, Sergi; Perez-Millan, Agnes; Antonell, Anna; Fort-Aznar, Laura; Kaya-Tilki, Elif;

(...)

Vitorica, Javier; Luis Venero, Jose; Deierborg, Tomas; Boza-Serrano, Antonio; Sanchez-Valle, Raquel.

Referència:
Alzheimers & Dementia 2024.
Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects

Rami, Lorena; Leon, Maria; Valech, Natalia; Coll-Padros, Nina; Bosch, Beatriz;

(...)

Salinero, Ana; Perez-Millan, Agnes; Molinuevo, Jose Luis; Sanchez-Valle, Raquel; Tort-Merino, Adria.

Referència:
Neuropsychology 2023.
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data

Pérez-Millan, A; Contador, J; Junc-Parella, J; Bosch, B; Borrell, L;

(...)

Rami, L; Balasa, M; Llad, A; Sánchez-Valle, R; Sala-Llonch, R.

Referència:
Human Brain Mapping 2023.